{"id":2716,"date":"2019-10-07T20:24:44","date_gmt":"2019-10-07T18:24:44","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2716"},"modified":"2024-04-11T11:28:54","modified_gmt":"2024-04-11T09:28:54","slug":"neumologia","status":"publish","type":"page","link":"https:\/\/idibell.cat\/recerca\/area-de-medicina-translacional\/programa-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cel%c2%b7lular\/neumologia\/","title":{"rendered":"Pneumologia"},"content":{"rendered":"\n
El grup de recerca en penumologia est\u00e0 centrat en la recerca de respostes a problemes cl\u00ednics respiratoris i solucions terap\u00e8utiques en malalties pneumol\u00f2giques sense tractaments efectius.<\/p>\n
<\/p>\n
Raghu,G;Remy Jardin,M; Richeldi,L; Thomson,CC; Inoue,Y; Johkoh,T; Kreuter,M et al, Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline<\/strong>, Am. J. Respir. Crit. Care Med., 2022;205(9):18-47, doi:10.1164\/rccm.202202-0399ST<\/p>\n R\u00fcschoff,JH;Haberecker,M;Tsourti,Z;Nackaerts,K;de Perrot,M; Brcic,L; Nadal,E et al, Expression of phosphorylated ribosomal protein S6 in mesothelioma patients – correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project<\/strong>., Mod. Pathol., 2022;35(12):1888-1899, doi:10.1038\/s41379-022-01145-0<\/p>\n Khor,YH;Bissell,B;Ghazipura,M;Herman,D;Hon,SM;Hossain,T;Kheir,F et al, Antacid Medication and Antireflux Surgery in Patients with Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis<\/strong>., Ann Am Thorac Soc, 2022;19(5):833-844, doi:10.1513\/AnnalsATS.202102-172OC<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t FIS22094. Integraci\u00f3n de las caracter\u00edsticas moleculares, gen\u00f3micas, morfol\u00f3gicas, y ambientales para mejorar el diagn\u00f3stico y tratamiento de precisi\u00f3n en Enfermedades Pulmonares Intersticiales Difusas fibrosantes (Precision-EPID)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 3049970. 2023-2025. PI: Molina Molina, Maria.<\/p>\n 20FIS038. EFECTO DE LORATADINA EN LINFANGIOLEIOMIOMATOSIS<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 263603,37. 2020-2023. PI: Molina Molina, Maria.<\/p>\n 19FIS033. Caracterizaci\u00f3n de la fibrosis pulmonar telom\u00e9rica y su regulaci\u00f3n biol\u00f3gica<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 177870. 2019-2022. PI: Molina Molina, Maria.<\/p>\n FIS21100. LOOKING FOR PREDICTIVE FACTORS AND PREVENTIVE MEASURES OF POSTCOVID19 INTERSTITIAL LUNG SEQUELAE<\/strong>. (POST-COVIL). Instituto de Salud Carlos III (ISCIII). Budget: 151250. 2022-2024. PI: Molina Molina, Maria.<\/p>\n 17ACL032. ESTUDIO OBSERVACIONAL EN VOLUNTARIOS SANOS Y PACIENTES CON EPOC PARA EVALUAR LA RELACI\u00d3N ENTRE LAS MEDICIONES CL\u00cdNICAS, RADIOL\u00d3GICAS Y DE BIOMARCADORES Y LA PROGRESI\u00d3N DEL ENFISEMA DURANTE UN PERIODO DE DOS A\u00d1OS<\/strong>. Boehringer Ingelheim Espa\u00f1a, S.A. Budget: 118222,88. 2017-2022. PI: Santos P\u00e9rez, Salud.<\/p>\n\t\t\t\t\tTransfer\u00e8ncia de tecnologia<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tLicense: Process for manufacturing a costomizable medical device and deviced obtained by said process Pneumologia Resum El grup de recerca en penumologia est\u00e0 centrat en la recerca de respostes a problemes cl\u00ednics respiratoris i solucions terap\u00e8utiques en malalties pneumol\u00f2giques sense tractaments efectius. 760 Publicacions L\u00ednies estrat\u00e8giques Expand Alteracions inflamat\u00f2ries i del remodelat pulmonar en malalties cr\u00f2niques prevalents com la MPOC i minorit\u00e0ries com la Fibrosi Pulmonar, o agudes […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":568,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-10 11:00:42","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2716"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=2716"}],"version-history":[{"count":11,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2716\/revisions"}],"predecessor-version":[{"id":25419,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/2716\/revisions\/25419"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/568"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=2716"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nPI: Dr. Antoni Rosell\nSpin-off: TRACTIVUS
\nPI: Dr. Antoni Rosell\n\t\t\t\t\n\n\t\tMolina Molina, Maria\n\t<\/h4>\n
\n\t\t\n\t\tmmolina@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSantos P\u00e9rez, Salud\n\t<\/h4>\n
\n\t\t\n\t\tmsantosp@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t\n
\n\t\tMolina Molina, Maria\n\t<\/h4>\n
\n\t\t\n\t\tmmolina@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSu\u00e1rez Cuart\u00edn, Guillermo Rafael\n\t<\/h4>\n
\n\t\t\n\t\tgsuarez@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tMonasterio Ponsa, Carmen\n\t<\/h4>\n
\n\t\tMonasterio Ponsa, Carmen\n\t<\/h4>\n\t\t\t\t\n
\n\t\tSantos P\u00e9rez, Salud\n\t<\/h4>\n
\n\t\t\n\t\tmsantosp@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tMu\u00f1oz Esquerre, Mariana Mercedes\n\t<\/h4>\n
\n\t\t\n\t\tmmunoz@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tD\u00edez Ferrer, Marta\n\t<\/h4>\n\t\t\t\t\n
\n\t\tC\u00f3rdoba Izquierdo, Ana\n\t<\/h4>\n
\n\t\t\n\t\tacordoba@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tVicens Zygmunt, Vanesa\n\t<\/h4>\n
\n\t\t\n\t\tvvicens@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tLopez Lisbona, Rosa Maria\n\t<\/h4>\n
\n\t\t\n\t\trmlopez@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\n
\n\t\tFarrero Mu\u00f1oz, Eva\n\t<\/h4>\n
\n\t\t\n\t\tefarrero@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n
\n\t\t\n\t\t@msaludsantos\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@EsquerreMunoz\n\t\t<\/a>\n\t<\/h4>\n
\n\t\t\n\t\t@Rosa96166501\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es postdoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport cient\u00edfic\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n
\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tMaria Molina, nova directora cient\u00edfica de l’IDIBELL<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t29\/02\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLes exposicions ambientals i els determinants socials s\u00f3n clau en pacients amb fibrosi pulmonar<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/01\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tLa Dra. Maria Molina \u00e9s nomenada nova directora cient\u00edfica de l’\u00c0rea de Malalties Respirat\u00f2ries del CIBER<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t27\/06\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDues investigadores de L’IDIBELL reben dos projectes de recerca en medicina personalitzada<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t08\/02\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls pacients amb Fibrosi Pulmonar Idiop\u00e0tica que segueixen una dieta mediterr\u00e0nia tenen menys efectes adversos gastrointestinals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/10\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUna nova guia internacional permet avan\u00e7ar en el diagn\u00f2stic i tractament de la fibrosi pulmonar progressiva<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t08\/06\/2022\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDescrits nous factors predictors de mortalitat en l’emb\u00f2lia pulmonar greu<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t05\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl trasplantament de pulm\u00f3 \u00e9s efectiu per als malalts de fibrosi pulmonar amb tel\u00f2mers curts<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/09\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting sobre els Projectes d’Investigaci\u00f3 en Salut concedits per l’ISCIII<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUn GPS bronquial basat en imatge digital per a la detecci\u00f3 preco\u00e7 del c\u00e0ncer de pulm\u00f3<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t10\/01\/2017\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"